Five Star Equities Provides Stock Research on Ameren and Pepco Holdings
Continue ReadingTag: research-reports
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals
Continue Reading
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences
Continue Reading
Special Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase
Five Star Equities Provides Stock Research on Health Care REIT and R.R. Donnelley & Sons
Continue Reading
Ethanol Stocks Struggle as E15 Fuel Fails to Gain Widespread Adoption
The Paragon Report Provides Stock Research on Green Plains Renewable Energy and Renewable Energy Group
Continue Reading
The Amount of Companies Paying Special Dividends in 2012 Is Four Times the Pace of 2011
Five Star Equities Provides Stock Research on Verizon and CenturyLink
Continue Reading
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Halozyme Therapeutics and Merrimack Pharmaceuticals
Continue Reading
Natural Gas Heating Demand Expected to Be 34% Below Average in the Coming Weeks
The Paragon Report Provides Stock Research on EnCana and Cheniere Energy
Continue Reading
Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms
Five Star Equities Provides Stock Research on Lockheed Martin and Pitney Bowes
Continue Reading
Forecasts for Warmer Temperatures and Lower Heating Demand Causes Natural Gas Prices to Fall Sharply
The Paragon Report Provides Stock Research on Devon Energy and Quicksilver Resources
Continue Reading